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Abstract: Cortical thickness has been suggested to be one of the most
important markers of cortical atrophy.
In this study, we examined potential risk factors of cortical thickness
and its association with cognition in an elderly Asian population from
Singapore.
This is a cross-sectional study among 572 Chinese and Malay
patients from the ongoing Epidemiology of Dementia in Singapore
(EDIS) Study, who underwent comprehensive examinations including
neuropsychological testing and brain magnetic resonance imaging
(MRI). Cortical thickness (in micrometers) was measured using a
model-based automated procedure. Cognitive function was expressed
as composite and domain-specific Z-scores. Cognitive impairment was
categorized into cognitive impairment no dementia (CIND)-mild,
CIND-moderate, and dementia in accordance with accepted criteria.
Linear regression models were used to examine the association between
various risk factors and cortical thickness. With respect to cognition as
outcome, both linear (for Z-scores) and logistic (for CIND/dementia)
regression models were constructed. Initial adjustments were made for
age, sex, and education, and subsequently for other cardiovascular risk
factors and MRI markers.
Out of 572 included patients, 171 (29.9%) were diagnosed with
CIND-mild, 197 (34.4%) with CIND-moderate, and 28 (4.9%) with
dementia. Risk factors related to a smaller cortical thickness were
increased age, male sex, Malay ethnicity, higher blood glucose, and
body mass index levels and presence of lacunar infarcts on MRI.
Smaller cortical thickness was associated with CIND moderate/demen-iro J. Niessen, Ph man, PhD,
, and Mohammad Kamran Ikram, MD, PhD
decrease: 0.094; 95% CI: 0.159; 0.030, P¼ 0.004]. In particular,
smaller cortical thicknesses in the occipital and temporal lobes were
related to cognitive impairment. Finally, in terms of specific cognitive
domains, the most significant associations were found for executive
function, visuoconstruction, and visual memory.
Smaller cortical thickness is significantly associated with cognitive
impairment, suggesting a contribution of diffuse cortical atrophy
beyond the medial temporal lobe to cognitive function. These findings
suggest that cortical thinning is a biomarker of neurodegenerative
changes in the brain not only in dementia, but also in its preclinical
stages.
(Medicine 94(23):e852)
Abbreviations: AD = Alzheimer disease, BOMBS = brain
observer microbleed scale, CIND = cognitive impairment no
dementia, EDIS = epidemiology of dementia in Singapore, FLAIR
= fluid attenuated inversion recovery, MCI = mild cognitive
impairment, SCES = Singapore Chinese Eye Study, SEED =
Singapore Epidemiology of Eye Diseases, SIMES = SingaporeMalay Eye Study, SINDI = Singapore Indian Eye Study, STRIVE =
standards for reporting vascular changes on neuroimaging.
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INTRODUCTION
Neurodegeneration – a hallmark of dementia – is charac-
terized by loss of neuronal tissue in both gray and white matter.
This brain atrophy is not only seen in clinically manifest
Alzheimer disease (AD), but may already be present in the
preclinical stages [for which the terms cognitive impairment no
dementia (CIND) or mild cognitive impairment (MCI) have
been coined].1–4 Furthermore, it has been suggested that these
brain changes may even be present during normal aging.5–8
Recent advances in neuroimaging enable us to assess early
age-related brain changes. Of particular interest is cortical
thickness, which reflects the width of the cortical gray matter,9to be a reliable marker of brain atro-
have shown that patients with AD have
rontal, temporal, and parietal regions
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(2)compared with controls, consistent with pathological patterns of
atrophy described in AD.1,11,12 In addition, a few studies have
suggested that even during the preclinical stages of dementia
cortical thinning is associated with worse performance on
cognitive tests.13,14 Overall, these studies were mainly limited
to Caucasian populations, had small sample sizes,15–17 and
lacked detailed neuropsychological tests.13,14
With respect to Asian populations, it has been proposed
that – besides neurodegeneration – cerebrovascular disease
may play a prominent role in the development of dementia due
to the higher prevalence of vascular risk factors among Asians
compared with Caucasians.18–21 Nevertheless, it remains
important to determine the exact role of neurodegeneration
in Asian populations, particularly in the preclinical stages of
dementia. Thus far, several studies from Korea have shown
regional differences in temporo-parietal and prefrontal regions
in both AD patients and patients with MCI compared with
controls.22–24 The association between cortical thickness and
cognitive impairment in elderly Asian populations has, how-
ever, not been explored extensively. We, therefore, examined
whether demographic and cardiovascular risk factors were
related to cortical thickness. Furthermore, we examined in an
elderly Asian population from Singapore the association of
global and lobe-specific cortical thicknesses with cognitive
impairment, including preclinical stages of dementia.
METHODS
Study Population
The ongoing Epidemiology of Dementia in Singapore
(EDIS) study draws participants from the Singapore Epidemiol-
ogy of Eye Disease (SEED) study, a multiethnic population-
based study among persons ages 40–85 years among Chinese
(Singapore Chinese Eye Study [SCES]), Malay (Singapore
Malay Eye Study [SiMES-2]), and Indians (Singapore Indian
Eye Study [SINDI-2]). For this study, we focused on Chinese25
and Malay components26 of the EDIS Study, as the recruitment
of the Indians is still ongoing. In the first phase of the EDIS
study, participants ages  60 years (n¼ 2666) were screened
using the abbreviated mental test and a self-report of progressive
forgetfulness. Screen-positive patients (n¼ 1097) were invited
to take part in the second phase of this study, which included an
extensive neuropsychological test battery and brain MRI. Of
these 1097 participants, 623 agreed to participate in phase II and
hence were included in the present study. The details of the
study methodology have been described elsewhere.25 Ethics
approval for EDIS study was obtained from the Singapore Eye
Research Institute, and National Healthcare Group Domain-
Specific Review Board. The study is conducted in accordance
with the Declaration of Helsinki. Written informed consent was
obtained in the preferred language of the participants by bilin-
gual study coordinators before their recruitment into the study.
Demographic and Cardiovascular Factor
Assessment
During a personal interview a detailed questionnaire was
administered to collect relevant demographic and medical
information. Data collection included among others age, sex,
race, and education. Previous medical history of hypertension,
hyperlipidemia, diabetes mellitus, was also noted and sub-
Hilal et alsequently verified by medical records. Functional status was
assessed using The Instrumental Activities of Daily Living
(IADL) questionnaire. Clinical assessments included height,
2 | www.md-journal.comweight, and blood pressure. As part of the examinations per-
formed in the SEED cohort, blood was drawn in the nonfasting
state to determine full blood count, total cholesterol, glucose,
and glycated hemoglobin levels.25
Systolic and diastolic blood pressures were measured using
a digital automatic blood pressure monitor (OMRON-HEM
7203, Japan) after the patient rested for 5 minutes. Blood
pressure was measured twice, 5 minutes apart. Mean of the 2
readings was considered the relevant blood pressure. Hyperten-
sion was defined as systolic blood pressure140mmHg and/or
diastolic blood pressure90mm Hg, or use of antihypertensive
medication. Mean arterial blood pressure was calculated as two-
thirds of the diastolic blood pressure plus one-third of the
systolic blood pressure. Diabetes mellitus was defined as gly-
cated hemoglobin 6.5%, or on medication. Hyperlipidemia is
defined as total cholesterol levels 4.14mmol/L, or on medi-
cation. Education was categorized into 6 years or >6 years of
primary education. Smoking was categorized into nonsmokers
and smokers (past and current smokers). Body mass index
(BMI) was calculated as the weight (kg) divided by the square
of the height (meters). IADL score was used as a sum score
(higher scores indicate poor functioning; range 0–26). Details
of all the study assessments have been described previously.25
Neuroimaging
MRI was performed on a 3 Tesla Siemens Magnetom Trio
Tim scanner, using a 32-channel head coil, at the Clinical
Imaging Research Centre of the National University of Singa-
pore. Patients with claustrophobia, contraindications for MRI,
or those who were unable to tolerate the procedure were
excluded. Quantitative MRI data were obtained by automatic
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Contation at the Department of Medical Informatics, Eras-
University Medical Center, The Netherlands. For each
cipant, the following MRI markers were computed:
Cortical thickness was calculated using a model-
based automated procedure (FreeSurfer, v.5.1.0) on T1-
weighted images (TR¼ 7.2ms, TE¼ 3.3ms, matrix¼
256 256 180mm3). Cortical thickness was measured
at each vertex by taking the shortest distance between
white matter/gray matter boundary and pial surface.27
Whole brain (global) and regional (lobar) averages of
cortical thickness were expressed in micrometers. Lobar
average was calculated from right and left thicknesses
using the parcellation guide on gyral and sulcal structures
of cerebral cortex.27 Lobar averages were calculated for
the frontal, parietal, occipital, temporal, insular, and
limbic regions.
Total brain and white matter lesions (WML) volumes were
also quantified by automatic segmentation. Total brain
volume was quantified on Proton density, T1- and T2-
weighted images, whereas the WML volume was
segmented using the fluid-attenuated inversion recovery
(FLAIR) sequence.28
Besides these quantitative MRI data, 1 radiologist and 2
clinicians graded the presence of lacunar infarcts and cerebral
microbleeds independently and blinded to all neuropsycholo-
gical and clinical data. Lacunar infarcts were graded on FLAIR
and T2 sequences using the STRIVE criteria.29 Cerebral micro-s were defined using Brain Observer Microbleed Scale
BS).30 Any disagreement was discussed during weekly
ensus meetings attended by study clinicians (neurologists),
pyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
radiologists, and clinical research fellows, and a final decision
was made during this meeting.
Cognitive Assessment
An extensive neuropsychological battery, which has been
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sess cognitive function.25 The following seven (5 non-to as
memory and 2 memory) domains were examined;
Executive Function (Frontal Assessment Battery, Maze(1)
Task),(2) Attention (Digit Span, Visual Memory Span, Auditory
Detection),(3) Language (Boston Naming Test, Verbal Fluency),
Visuomotor speed (Symbol Digit Modality Test, Digit
Cancellation),
Visuoconstruction [Weschler Memory Scale – Revised(5)
(WMS-R) Visual Reproduction Copy task, Clock Draw-
ing, Weschler Adult Intelligence Scale – Revised (WAIS-
R) subtest of Block Design],(6) Verbal Memory (Word List Recall, Story Recall),
(7) Visual Memory (Picture Recall and WMS-R Visual
Reproduction).For each participant, raw scores from each individual test
n a domain were first transformed to standardized Z-scores
the mean and standard deviation [SD] of that test in this
E 1. Baseline Characteristics of Study Participants
All Patients
(n¼ 572)
NCI
(n¼ 176)
years (SD) 70.5 (6.77) 67.2 (5.06)
en, n (%) 313 (54.7) 74 (42)
n (%)
inese 275 (48.1) 123 (69.9)
lays 297 (51.9) 53 (30)
mary education
6 years, n (%)
157 (27.4) 83 (47.2)
trumental activities of
aily living (SD)
8.1 (2.8) 7.2 (0.6)
pertension, n (%) 459 (80.2) 135 (76.7)
betes, n (%) 172 (30.1) 43 (24.4)
perlipidemia, n (%) 388 (67.8) 108 (61.4)
an arterial blood pressure,
m Hg (SD)
97.89 (10.7) 100.3 (10.4)
nfasting blood glucose,
mol/L, (SD)
6.88 (2.92) 6.5 (2.6)
al cholesterol, mmol/L (SD) 5.22 (1.18) 5.0 (0.9)
oking, n (%) 76 (25.6) 54 (30.7)
dy mass index, kg/m2 (SD) 22.2 (4.11) 19.9 (3.2)
al intracranial volume,
L (SD)
1074.8 (120.9) 1108.8 (106.5)
sence of lacunar
nfarcts, n (%)
112 (19.6) 13 (7.4)
ite matter lesions, mL,
edian (IQR)
1.91 (5.27) 1.3 (3.1)
ebral microbleeds, no. (%) 201 (35.1) 49 (27.8)
bal cortical thickness,
m, mean (SD)
2362.0 (108.9) 2404.1 (94.3)
D¼ cognitive impairment no dementia; IQR¼ interquartile range;
l/L¼millimoles per liter; mm¼micrometers; n¼ number; NCI¼ no c
perscript letters indicate representing group is significantly different fr
0.05).
right # 2015 Wolters Kluwer Health, Inc. All rights reserved.cohort. A higher Z-score reflected a better performance on that
test. Subsequently, for each participant a mean Z-score for each
domain was calculated by averaging the Z-scores of all the
individual tests within that domain. These mean Z-scores of
each domain were then standardized using the mean and SD of
that domain-specific mean Z-score. Finally, composite Z-score
reflecting global cognitive functioning was calculated by aver-
aging the 7 domain-specific mean Z-scores, which were also
standardized using the corresponding mean and SD.
The diagnosis of CIND was determined by clinical judg-
ment and was anchored in the following guidelines, as pre-
viously published,31 namely, self and/or informant report of
problems with cognition without any significant loss of inde-
pendence in daily activities, and impairment in at least 1 domain
of the neuropsychological test battery. Participants were con-
sidered to have failed a test if they scored 1.5 SD below
education-adjusted cut-off values on each individual test. Fail-
ure in at least half of the tests in each domain was considered
impairment in that domain. CIND was classified into mild
(when 2 domains were impaired) and moderate (when >2
domains were impaired). The diagnosis of dementia was made
according to the DSM-IV criteria.
STATISTICAL ANALYSIS
Risk Factors and Consequences of Cortical ThicknessTo examine differences in baseline characteristics between
included and excluded patients, x2 test was used for categorical
variables and Student t test for continuous variables. Trends in
CIND Mild
(n¼ 171)
CIND Moderate
(n¼ 197)
Dementia
(n¼ 28)
P for
trend
70.1 (6.06)a 73.6 (6.58)a,b 78.9 (5.11)a,b,c <0.001
83 (48.5) 132 (67)a,b 24 (85.7)a,b <0.001
75 (43.9) 73 (37.1) 4 (14.3) <0.001
96 (56.1)a 124 (62.9)a 24 (85.7)a,b
42 (24.6)a 28 (14.2)a 0 <0.001
7.5 (1.2) 8.6 (2.5)a,b 16.5 (6.4)a,b,c <0.001
140 (81.9) 175 (88.8)a 25 (89.3) 0.001
49 (28.7) 69 (35) 12 (42.9) 0.008
118 (69) 155 (78.7)a 20 (71.4) 0.001
101.1 (10.1) 99.6 (10.9) 104.9 (13.3) 0.750
7.0 (3.2) 6.9 (2.7) 7.9 (4.2) 0.054
5.0 (1.0) 5.1 (1.3) 5.1 (1.1) 0.777
57 (33.3) 52 (26.4) 2 (7.1) 0.078
19.9 (3.7) 19.6 (3.6) 17.7 (4.3)a,b 0.019
1072.6 (131.6)a 1054.8 (102.6)a 1001.3 (195.3)a,b <0.001
30 (17.5) 56 (28.4)a,b 13 (46.4)a,b <0.001
1.6 (4.2) 2.9 (7.4) 8.5 (15.6) <0.001
62 (36.3) 78 (39.6) 12 (42.9) 0.002
2366.6 (100.0)a 2334.1 (112.3)a 2266.6 (108.1)a,b,c <0.001
kg/m2¼ kilogram per meter square; mm Hg¼millimeter of mercury;
ognitive impairment; SD¼ standard deviation.
om NCI (a), CIND mild (b), or CIND moderate (c) based on ANOVA
www.md-journal.com | 3
baseline characteristics across different diagnostic groups were
examined using analysis of variance (ANOVA) and a P-value
for the trend test was computed.
Associations of potential demographic and cardiovascular
risk factors with global and lobar cortical thicknesses were
explored using multiple linear regression models. All continu-
ous variables (age, mean arterial blood pressure, nonfasting
blood glucose, total cholesterol, BMI, total intracranial
volume) were standardized (by dividing each variable by its
SD). For each continuous variable, mean differences in cortical
thicknesses were expressed per SD increase/decrease in that
variable. Model I was adjusted for age, sex, and education.
Subsequently, in the fully adjusted model (Model II), all
potential risk factors were included in the same model to
determine the independent effect of each potential factor with
cortical thickness.
Next, we examined the associations of global and lobar
cortical thicknesses with clinical outcomes (CIND and demen-
tia) using logistic regression models [odds ratios (OR) with 95%
confidence interval (CI)] and with composite Z score using
linear regression models [mean difference with 95% CI]. The
effect sizes of these associations with cognition were expressed
per SD decrease in cortical thickness.
P-values<0.05 were considered statistically significant. In
view of the multiple tests performed in the lobe-specific
analyses, we used Bonferroni correction to obtain a revised
statistical significance level of 0.05/6–0.008. Furthermore, we
used revised levels of statistical significance for the cognitive
domain-specific analyses: 0.05/7–0.007 when analyzing the
associations with global cortical thickness, and 0.05/76–
0.001 when analyzing the associations with lobar cortical
Hilal et althicknesses. Statistical analysis was performed using standard
statistical software (Statistical Package for Social Sciences,
SPSS V22, SPSS Inc, Chicago, IL).
TABLE 2. Multivariable Adjusted Associations Between Potential
Model I

Difference (
Age (years), per SD decrease 36.7 (45.6
Gender (women vs men) 34.7 (17.4;
Primary education >6 years 16.0 (4.8;
Ethnicity (Malay vs Chinese) 63.1 (79.0
Instrumental activities of daily living, per score increase 6.14 (9.3;
Mean arterial blood pressure (mm Hg), per SD increase 1.3 (9.8;
Nonfasting blood glucose (mmol/l), per SD increase 14.3 (22.8
Total cholesterol (mmol/L), per SD increase 3.6 (5.1;
Smoking (yes vs no) 1.6 (24.3
Body mass index (kg/m2), per SD increase 15.9 (24.4
Intracranial volume (mL), per SD increase 2.5 (12.3
Presence of lacunar infarcts 41.6 (63.1
White matter lesions (mL, log-transformed)
per SD increase
32.3 (52.7
Per cerebral microbleed increase 0.8 (1.6;
CI¼ confidence interval; kg/m2¼ kilogram per meter square; Log¼ log
L¼millimoles per liter; mm¼micrometer; SD¼ standard deviation.
Model I adjusted for age, sex, and education.
yModel II fully adjusted for age, sex, education, race, nonfasting blood g
presence of lacunes, white matter lesions volume, number of cerebral micro
z In Model I, the effect sizes for these three variables were from a basic
4 | www.md-journal.comRESULTS
Assessments of study participants were performed from
August 12, 2010 to December 21, 2013. Out of 623 patients
who participated in phase II, 36 had no MRI scans and 3 had
ungradable scans. Furthermore, 12 patients who had a cortical
infarct were excluded, as these infarcts may influence the cortical
thickness measurements. Supplementary Table 1, http://
links.lww.com/MD/A261 presents baseline data of both the
included and excluded patients. In brief, excluded patients were
likely to be older, were more often Chinese, had lower education,
a higher frequency of hypertension and a lower frequency of
hyperlipidemia. Out of 572 included patients, 171 (29.9%) were
diagnosed with CIND-mild, 197 (34.4%) with CIND-moderate,
and 28 (4.9%) with dementia. Table 1 provides baseline charac-
teristics of the included participants according to the different
diagnostic groups. In brief, increasing age, female patients,Malay
ethnicity, higher proportion of hypertension, diabetes, and hyper-
lipidemia were related to severity of cognitive impairment. Also,
an increasing frequency was observed for several MRI markers.
Conversely, a decreasing trendwas observed for education, BMI,
total intracranial volume, and IADL.
Table 2 shows the association of potential risk factors with
mean global cortical thickness. In fully adjusted models (Model
II), the most important risk factors of cortical thickness were:
increasing age [mean difference in cortical thickness per SD
increase in age: 30.9mm; 95% CI: 40.2; 21.7; P< 0.001],
sex [women vs men: 25.4mm; 95% CI: 2.1; 48.7; P¼ 0.029],
Malay ethnicity [Malay vs Chinese:57.4mm; 95% CI:74.5;
40.3; P< 0.001], BMI [mean difference per SD increase in
BMI: 9.5; 95% CI: 18.1; 0.8; P¼ 0.022], and presence of
Medicine  Volume 94, Number 23, June 2015lacunar infarct [presence vs absence: 25.8; 95% CI: 48.6;
3.1; P¼ 0.034]. A borderline significant association was
observed for nonfasting glucose levels [mean difference per
Risk Factors and Global Cortical Thickness (n¼572)
Global Cortical Thickness (mm)
Mean
95% CI)
P
Value
Model IIy Mean
Difference (95% CI)
P
value
; 27.8)z <0.001 30.9 (40.2; 21.7) <0.001
52.0)z <0.001 25.4 (2.1;48.7) 0.029
36.8)z 0.131 5.3 (14.9; 25.5) 0.606
; 47.3) <0.001 57.4 (74.5; 40.3) <0.001
2.9) <0.001 2.43 (5.8; 0.9) 0.161
7.2) 0.758 4.8 (3.6; 13.2) 0.242
; 5.8) 0.001 8.1 (16.4; 0.3) 0.059
12.2) 0.418 4.4 (4.1; 12.9) 0.322
; 21.0) 0.888 1.8 (23.7; 20.1) 0.860
; 7.6) <0.001 9.5 (18.1; 0.8) 0.022
; 7.3) 0.619 2.1 (12.0; 7.8) 0.612
; 20.1) <0.001 25.8 (48.6; 3.1) 0.034
; 11.9) 0.002 16.5 (38.7; 5.8) 0.169
0.0) 0.051 0.5 (1.2; 0.3) 0.300
transformed; mL¼millilitres; mm Hg¼millimeter of mercury; mmol/
lucose, blood cholesterol, mean arterial blood pressure, BMI, smoking,
bleeds, intracranial volume, and independent activities of daily living.
model containing only age, sex, and education.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
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Risk Factors and Consequences of Cortical ThicknessSD increase in glucose levels: 8.1mm; 95% CI: 16.4; 0.3;
P¼ 0.059].
The association between potential risk factors and lobe-
specific cortical thickness is presented in supplementary Table
2, http://links.lww.com/MD/A261. After Bonferroni correction,
the most consistent associations with smaller cortical thick-
nesses across the different lobes were found for increasing age
and Malay ethnicity. Women had thicker cortical thicknesses in
particular in the parietal and temporal lobes. The association
between higher BMI and smaller cortical thickness was most
prominent in the frontal region [mean difference per SD
increase in BMI: 14.7; 95% CI: 23.9; 5.45; P¼ 0.002].
In terms of MRI markers of cerebral small vessel disease, white
matter lesions were associated with temporal thinning, whereas
increasing number of microbleeds were related to insular
thinning.
With respect to clinical outcomes (Table 3), smaller global
cortical thickness was significantly associated with CIND mod-
erate/dementia [OR: 1.70; 95% CI: 1.19–2.44; P¼ 0.004]. This
association persisted even after excluding 28 dementia cases
[OR: 1.69; 95% CI: 1.18–2.43; P¼ 0.004]. Smaller cortical
thickness was also related to poorer global cognitive functioning
as reflected by the composite Z-scores [mean difference compo-
site Z-score per SD decrease in cortical thickness: 0.094; 95%
CI:0.159;0.030, P¼ 0.004]. Lobe-specific analyses showed
that these associations were mainly driven by the parietal,
occipital, temporal, and limbic lobes. Specifically, the associ-
ationswith the temporal and occipital lobes remained statistically
significant after Bonferroni correction.
Finally, in the domain-specific analyses (Table 4), global
cortical thickness was related to executive function [mean
difference per SD decrease in cortical thickness: 0.129;
95% CI: 0.207; 0.051; P¼ 0.001], visuoconstruction [mean
difference per SD decrease in cortical thickness: 0.099; 95%
CI: 0.172; 0.027; P¼ 0.007] and visual memory [mean
difference per SD decrease in cortical thickness: 0.111;
95% CI: 0.183; 0.039; P¼ 0.003]. In the lobe-specific
analyses, the most consistent associations at the nominal sig-
nificance level of 0.05 were found between the occipital and
temporal lobes with the various cognitive domains. However,
after applying Bonferroni correction, most of these associations
did not remain statistically significant.
DISCUSSION
In this study, we found that persons with smaller cortical
thickness – in particular in the temporal and occipital lobes –
were more likely to have cognitive impairment, including the
preclinical stages of dementia. More specifically, these
persons performed worse on tasks in executive function, visuo-
construction, and visual memory. Finally, the most important
risk factors were increasing age, male sex, Malay ethnicity,
increased blood glucose, high BMI, and presence of lacunar
infarction on MRI.
Several studies reported a smaller global cortical thickness
with increasing age.7,32,33 Across these studies this effect of age
was, however, variable with some reporting the largest decrease
in frontal and temporal lobes,32 whereas others found the
strongest effects in the occipital and parietal regions.6,34 The
wide age distribution of these studies (ranging from 18 to 82
years) may underlie these differences. Despite these variations,
Medicine  Volume 94, Number 23, June 2015the overall trend – that increasing age was related to smaller
cortical thickness – is similar across all these studies, which is
further supported by our present findings. T
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In our study women had relatively thicker cortex compared
with men. This sex difference may be related to the protective
effect of estrogen on neurodegeneration.35 This is in line with
other studies reporting similar sex differences in cortical thick-
ness.27 In terms of ethnic differences, Malays had a thinner
global and lobe-specific cortical thicknesses compared with
Chinese. A higher prevalence of vascular risk factors (hyper-
tension, diabetes, and hyperlipidemia) and a higher frequency of
Apoe4 carriers have been reported amongMalays. These factors
may lead to an increased susceptibility to neurodegeneration in
Malays and hence may underlie this difference.36
With respect to cardiovascular risk factors, we found – in
accordance with other studies – that increased blood glucose
levels were associated (borderline significantly) with global
cortical thinning.15,27,37 The mechanisms leading to neurode-
generation are linked to episodes of hypo- and hyperglycemia,
alterations to the blood–brain barrier, and increased production
of glycated endproducts.38,39 Besides glucose levels, an inde-
pendent association was found for BMI, especially in the frontal
lobe. A previous study suggested that adiposity was associated
with frontal gray matter atrophy in middle and old aged persons,
possibly through increased vascular pathology and reduced
blood supply eventually leading to brain atrophy.40 Further
studies are needed to elucidate the exact mechanisms through
which BMI and adiposity are related to atrophy. Finally, several
MRI markers of cerebral small vessel disease showed some
associations with smaller global and lobe-specific cortical
thicknesses, indicating an interaction between cerebrovascular
and neurodegenerative processes.41–43
With respect to cognition, we found that a smaller global
cortical thickness is linked to cognitive impairment, suggesting
that diffuse atrophy beyond medial temporal lobe and hippo-
campus atrophy is already present in the preclinical stages of
dementia.24 More specifically, thinner cortex in temporal and
occipital lobes showed consistent patterns with worse perform-
ance in all cognitive domains. Patho-physiologically, the
temporal and occipital lobes may show thinning in the early
stages of dementia, as these regions are especially susceptible to
the toxic effects of neurofibrillary tangles and amyloid pla-
ques,44,45 and hence are early sites for these depositions. It has
been reported that the burden of these depositions was corre-
lated with the extent of atrophy and reduced metabolism in these
regions,46 and functionally with cognitive dysfunction. Our
present findings suggest that in Asian populations, besides
the contribution of cerebrovascular disease, neurodegeneration
as reflected by cortical thickness plays an important role in
cognitive impairment, including the preclinical stages
of dementia.
Limitations of the study include: first, 47.9% of the
screened positive patients were excluded from these analyses.
Compared with the included participants, these excluded
patients were relatively older, less educated, and more likely
to have hypertension and hyperlipidemia. Despite this nonpar-
ticipation, we however still found significant associations with
cortical thickness. Furthermore, these excluded patients might
be more cognitively impaired, suggesting that the reported
effect sizes in this study might be an underestimation. Second,
due to the cross-sectional design of our study the temporal
relationship between the presence of cortical thickness and
cognitive impairment could not be assessed. Third, due to
the small number of cases with dementia, we were not able
Medicine  Volume 94, Number 23, June 2015to examine these cases separately in multivariable models as
this resulted in unstable effect sizes and wide confidence
intervals. However, the dose–response relationship with the
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.preclinical stages of cognitive impairment suggests that these
findings may also be extendable to dementia. Strengths of the
study include: patients were selected from a population-
based study, extensive neuropsychological tests were used to
diagnose cognitive impairment and dementia, and automated
and standardized image processing was used to quantify cortical
thickness.
In conclusion, persons with smaller cortical thickness – in
particular in the temporal and occipital lobes – were more likely
to have cognitive impairment, suggesting a contribution of
diffuse cortical atrophy beyond the medial-temporal lobe to
cognitive function. These findings support the notion that
cortical thinning is a biomarker of neurodegenerative changes
in the brain not only in dementia, but also in its preclinical
stages.
REFERENCES
1. Frisoni GB, Testa C, Zorzan A, et al. Detection of grey matter loss
in mild Alzheimer’s disease with voxel based morphometry. J
Neurol Neurosurg Psychiatry. 2002;73:657–664.
2. Karas G, Sluimer J, Goekoop R, et al. Amnestic mild cognitive
impairment: structural MR imaging findings predictive of conversion
to Alzheimer disease. AJNR Am J Neuroradiol. 2008;29:944–949.
3. Karas GB, Scheltens P, Rombouts SA, et al. Global and local gray
matter loss in mild cognitive impairment and Alzheimer’s disease.
Neuroimage. 2004;23:708–716.
4. Trivedi MA, Wichmann AK, Torgerson BM, et al. Structural MRI
discriminates individuals with mild cognitive impairment from age-
matched controls: a combined neuropsychological and voxel based
morphometry study. Alzheimers Dement. 2006;2:296–302.
5. Lemaitre H, Goldman AL, Sambataro F, et al. Normal age-related
brain morphometric changes: nonuniformity across cortical thickness,
surface area and gray matter volume? Neurobiol Aging.
2012;33:617e611–e619.
6. Long X, Liao W, Jiang C, et al. Healthy aging: an automatic
analysis of global and regional morphological alterations of human
brain. Acad Radiol. 2012;19:785–793.
7. Magnotta VA, Andreasen NC, Schultz SK, et al. Quantitative in vivo
measurement of gyrification in the human brain: changes associated
with aging. Cereb Cortex. 1999;9:151–160.
8. Preul C, Hund-Georgiadis M, Forstmann BU, et al. Characterization
of cortical thickness and ventricular width in normal aging: a
morphometric study at 3 Tesla. J Magn Resonance Imaging.
2006;24:513–519.
9. Fischl B, Dale AM. Measuring the thickness of the human cerebral
cortex from magnetic resonance images. Proc Natl Acad Sci USA.
2000;97:11050–11055.
10. Singh V, Chertkow H, Lerch JP, et al. Spatial patterns of cortical
thinning in mild cognitive impairment and Alzheimer’s disease.
Brain. 2006;129:2885–2893.
11. Lerch JP, Pruessner JC, Zijdenbos A, et al. Focal decline of cortical
thickness in Alzheimer’s disease identified by computational neuroa-
natomy. Cereb Cortex. 2005;15:995–1001.
12. Sabuncu MR, Desikan RS, Sepulcre J, et al. The dynamics of
cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol.
2011;68:1040–1048.
Risk Factors and Consequences of Cortical Thickness13. Chang YL, Jacobson MW, Fennema-Notestine C, et al. Level of
executive function influences verbal memory in amnestic mild
cognitive impairment and predicts prefrontal and posterior cingulate
thickness. Cereb Cortex. 2010;20:1305–1313.
www.md-journal.com | 7
14. Paajanen T, Hanninen T, Aitken A, et al. CERAD neuropsychologi-
cal total scores reflect cortical thinning in prodromal Alzheimer’s
disease. Dement Geriatr Cogn Dis Extra. 2013;3:446–458.
15. Brundel M, van den Heuvel M, de Bresser J, et al. Cerebral cortical
thickness in patients with type 2 diabetes. J Neurol Sci.
2010;299:126–130.
16. Leritz EC, Salat DH, Williams VJ, et al. Thickness of the human
cerebral cortex is associated with metrics of cerebrovascular health
in a normative sample of community dwelling older adults. Neuro-
image. 2011;54:2659–2671.
17. Luders E, Narr KL, Thompson PM, et al. Gender effects on cortical
thickness and the influence of scaling. Hum Brain Mapp.
2006;27:314–324.
18. Mok V, Srikanth V, Xiong Y, et al. Race-ethnicity and cerebral
small vessel disease: comparison between Chinese and White
populations. Int J Stroke. 2014;100:36–42.
19. Khattar RS, Swales JD, Senior R, et al. Racial variation in
cardiovascular morbidity and mortality in essential hypertension.
Heart. 2000;83:267–271.
20. Xu G, Meyer JS, Huang Y, et al. Cross-cultural comparison of mild
cognitive impairment between China and USA. Curr Alzheimer Res.
2004;1:55–61.
21. Catindig JA, Venketasubramanian N, Ikram MK, et al. Epidemiology
of dementia in Asia: insights on prevalence, trends and novel risk
factors. J Neurol Sci. 2012;321:11–16.
22. Seo SW, Im K, Lee JM, et al. Effects of demographic factors on
cortical thickness in Alzheimer’s disease. Neurobiol Aging.
2011;32:200–209.
23. Ye BS, Seo SW, Yang JJ, et al. Comparison of cortical thickness in
patients with early-stage versus late-stage amnestic mild cognitive
impairment. Eur J Neurol. 2014;21:86–92.
24. Seo SW, Im K, Lee JM, et al. Cortical thickness in single- versus
multiple-domain amnestic mild cognitive impairment. Neuroimage.
2007;36:289–297.
25. Hilal S, Ikram MK, Saini M, et al. Prevalence of cognitive
impairment in Chinese: epidemiology of dementia in Singapore
study. J Neurol Neurosurg Psychiatry. 2013;84:686–692.
26. Rosman M, Zheng Y, Wong W, et al. Singapore Malay Eye Study:
rationale and methodology of 6-year follow-up study (SiMES-2).
Clin Exp Ophthalmol. 2012;40:557–568.
27. van Velsen EF, Vernooij MW, Vrooman HA, et al. Brain cortical
thickness in the general elderly population: the Rotterdam Scan
Study. Neurosci Lett. 2013;550:189–194.
28. Hilal S, Saini M, Tan CS, et al. Ankle-brachial index, cognitive
impairment and cerebrovascular disease in a Chinese population.
Neuroepidemiology. 2014;42:131–138.
Hilal et al29. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards
for research into small vessel disease and its contribution to ageing
and neurodegeneration. Lancet Neurol. 2013;12:822–838.
8 | www.md-journal.com30. Cordonnier C, Potter GM, Jackson CA, et al. improving interrater
agreement about brain microbleeds: development of the Brain
Observer MicroBleed Scale (BOMBS). Stroke. 2009;40:94–99.
31. Hilal S, Saini M, Tan CS, et al. Intracranial stenosis, cerebrovascular
diseases, and cognitive impairment in Chinese. Alzheimer Dis Assoc
Disord. 2015;29:12–17.
32. Fjell AM, Westlye LT, Amlien I, et al. High consistency of regional
cortical thinning in aging across multiple samples. Cereb Cortex.
2009;19:2001–2012.
33. Salat DH, Buckner RL, Snyder AZ, et al. Thinning of the cerebral
cortex in aging. Cereb Cortex. 2004;14:721–730.
34. Ziegler DA, Piguet O, Salat DH, et al. Cognition in healthy aging is
related to regional white matter integrity, but not cortical thickness.
Neurobiol Aging. 2010;31:1912–1926.
35. Cowell PE, Sluming VA, Wilkinson ID, et al. Effects of sex and age
on regional prefrontal brain volume in two human cohorts. Eur J
Neurosci. 2007;25:307–318.
36. Venketasubramanian N, Sahadevan S, Kua EH, et al. Interethnic
differences in dementia epidemiology: global and Asia-Pacific
perspectives. Dement Geriatr Cogn Disord. 2010;30:492–498.
37. Wisse LE, de Bresser J, Geerlings MI, et al. Global brain atrophy
but not hippocampal atrophy is related to type 2 diabetes. J Neurol
Sci. 2014;344:32–36.
38. Schmidt R, Launer LJ, Nilsson LG, et al. Magnetic resonance
imaging of the brain in diabetes: the Cardiovascular Determinants of
Dementia (CASCADE) Study. Diabetes. 2004;53:687–692.
39. Lunetta M, Damanti AR, Fabbri G, et al. Evidence by magnetic
resonance imaging of cerebral alterations of atrophy type in young
insulin-dependent diabetic patients. J Endocrinol Investig.
1994;17:241–245.
40. Willette AA, Kapogiannis D. Does the brain shrink as the waist
expands? Ageing Res Rev. 2015;20C:86–97.
41. Iadecola C. The overlap between neurodegenerative and vascular
factors in the pathogenesis of dementia. Acta Neuropathol.
2010;120:287–296.
42. Thong JY, Hilal S, Wang Y, et al. Association of silent lacunar
infarct with brain atrophy and cognitive impairment. J Neurol
Neurosurg Psychiatry. 2013;84:1219–1225.
43. Jouvent E, Viswanathan A, Chabriat H. Cerebral atrophy in
cerebrovascular disorders. J Neuroimaging. 2010;20:213–218.
44. Lewis DA, Campbell MJ, Terry RD, et al. Laminar and regional
distributions of neurofibrillary tangles and neuritic plaques in
Alzheimer’s disease: a quantitative study of visual and auditory
cortices. J Neurosci. 1987;7:1799–1808.
45. Hof PR, Morrison JH. Quantitative analysis of a vulnerable subset of
pyramidal neurons in Alzheimer’s disease: II. Primary and secondary
visual cortex. J Comparative Neurol. 1990;301:55–64.
Medicine  Volume 94, Number 23, June 201546. Buckner RL, Snyder AZ, Shannon BJ, et al. Molecular, structural,and functional characterization of Alzheimer’s disease: evidence for
a relationship between default activity, amyloid, and memory. J
Neurosci. 2005;25:7709–7717.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
